Search

Search Constraints

You searched for: Author/Creator Adamson, Carly

Search Results

2. Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction. (10th March 2023)

4. Coronary perforation incidence, outcomes and temporal trends (COPIT): a systematic review and meta-analysis. Issue 2 (21st October 2022)

5. Dapagliflozin for heart failure according to body mass index: the DELIVER trial . (27th August 2022)

6. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial. (22nd November 2021)

7. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial. (December 2021)

8. Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index. (29th July 2021)

9. Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new Chronic Kidney Disease Epidemiology Collaboration creatinine equation for estimating glomerular filtration rate. (8th March 2022)

10. Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF. Issue 6 (20th April 2022)